IBI provides the biopharmaceutical industry with comprehensive coverage of key scientific, technology, regulatory and business topics.
The editorial mix of peer-reviewed papers, practical advice on managing bioprocessing and technology, regulatory and business columns, and expert commentary provides comprehensive coverage of upstream and downstream processing, manufacturing operations, regulations, formulation, scale-up/technology transfer, drug delivery, analytical testing and more.
The insight and analysis covers biologic – based therapies including We will report on emerging trends, strategies and best practices in the key areas.
IBI Publishes, Peer Reviewed papers in the form of technical case studies, application notes; topical literature or patent reviews; novel research; or science based opinion papers. All papers undergo a peer review process by IBI’s Editorial Advisory Board of scientists, managers, directors and consultants.